+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID06542796

Evaluating Treatment Effects and Predicting Outcomes for Advanced Liver Cancer Using Immune and Targeted Therapies

Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2025-02-10

100

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the effectiveness of a new model to evaluate comprehensive treatment for hepatocellular carcinoma HCC, a common and deadly liver cancer. The model uses factors like PD-L1 expression, tertiary lymphoid structures TLS, and vascular endothelial growth factor VEGF levels to predict treatment outcomes. This study aims to help classify patients accurately and guide treatment decisions by comparing comprehensive therapy involving immunotherapy and targeted therapy to standard treatment plans. Participants will be randomly assigned to one of two groups one receiving immunotherapy combined with targeted therapy, and the other receiving the standard treatment plan. The study will assess the efficacy of these approaches using the constructed predictive model. This randomized controlled trial is based on prior retrospective analysis and intends to validate the models accuracy and practical use. During the study, patients will be followed for about one year after treatment to evaluate treatment effectiveness and the predictive accuracy of the model. Researchers will monitor long-term outcomes and use measures like sensitivity, specificity, and the area under the receiver operating characteristic ROC curve to assess the models performance. This follow-up will help determine how well the model predicts patient responses to comprehensive treatment for liver cancer.

CONDITIONS

Brief Title

Study on the Classification of Comprehensive Treatment Effect of Hepatocellular Carcinoma

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here